[A project of the 6th chapter of the Oncology Research Group, Aichi Prefectural Society of Hospital Pharmacists: an attempt to make a pamphlet for patients undergoing LEED therapy, based on analysis of complications].
To date, medical guidance for patients undergoing cancer chemotherapy has mainly been with regard to individual medicines. Only a few reports have been available dealing with information on side effects by a regimen unit. Therefore, we accumulated information on side effects and made a pamphlet for patients with malignant lymphoma undergoing peripheral blood stem cell transplantation after Melphalan (L-PAM), Cyclophosphamide (Endoxan), VP-16 (etoposide) and Dexamethasone (LEED)therapy, for the purpose of explanation for patients on pharmacist's rounds. This pamphlet consists of time schedule of anticancer therapy, harmful phenomena due to cancer chemotherapy and counterplans for such side effects. Easy-to-understand graphics are used to explain the appearance and duration of side effects by anticancer agents. This pamphlet will serve to improve comprehension and the attitude of patients toward cancer chemotherapy. The pamphlets will also be a useful tool to reassure patients on pharmacist's rounds.
Mori
Akiya
A
Hada
Katsuhiko
K
Kato
Tomotsugu
T
Hiraishi
Yayoi
Y
Maeda
Tohru
T
Tanaka
Yuka
Y
Niimi
Hiroyuki
H
Mizuno
Keiji
K
Ikeda
Yoshiaki
Y
Sekido
Izumi
I
Kimura
Kengo
K
Nakamura
Yuko
Y
Saito
Hiroko
H
Hasegawa
Shinsaku
S
D003907:Dexamethasone / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006761:Hospitals; D006801:Humans; D008495:Medical Oncology; D010174:Pamphlets; D010353:Patient Education as Topic; D010361:Patients; D010595:Pharmacists; D012955:Societies, Medical
D003907:Dexamethasone